Well-established diagnostic biomarkers for liver fibrosis, including alpha-2-macroglobulin (A2M) [5] and von Willebrand factor (VWF) [6], have significant drawbacks, such as insufficient specificity and individual variability. Here, VWF is linked to Hepatic fibrosis.